COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Pathophysiology
Last updated: 2025 Jul 18
Total hit(s): 29578
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
40626599
Respiratory admissions and impact of COVID-19 lockdowns for children with severe cerebral palsy.
N/A
Dev Med Child Neurol
2025 Jul 8
1
2
40638836
The Heterogenous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination: A Multicenter Report and Review of the Literature.
N/A
Retina
2025 Jul 8
6.7
1
3
40654050
Excess respiratory, circulatory, neoplasm and other mortality rates during the Covid-19 pandemic in the EU and their implications.
N/A
Epidemiol Infect
2025 Jul 14
2.01
1
4
40658046
Letter: Comment on "Association of Inhaled Corticosteroid Use with COVID-19 Severity and Hospitalization in Patients with and Without Respiratory Disease".
N/A
J Aerosol Med Pulm Drug Deliv
2025 Jul 14
5
1
5
40652932
Response to letter on : The methodological considerations of the inhaled Aviptadil trial for COVID-19 related lung damage.
N/A
Med Princ Pract
2025 Jul 11
3.8
1
6
40640175
Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.
N/A
NPJ Vaccines
2025 Jul 10
4.98
1
7
40306770
Corrigendum to "Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation" [Carbohydr. Polym. 332 (2024) 121884].
N/A
Carbohydr Polym
2025 Jul 1
6.23
1
8
40473523
Reply to comment on "Microbial dynamics, risk factors and outcomes of secondary pneumonia in critically ill patients with COVID-19".
N/A
J Formos Med Assoc
2025 Jun 4
2.16
1
9
40587211
Impact of COVID-19 Pandemic on Interstitial Lung Disease Healthcare Utilization & Outcomes: A Population Study in Alberta, Canada.
N/A
Ann Am Thorac Soc
2025 Jun 30
3.23
1
10
40288946
Prophylactic effects of nirmatrelvir/ritonavir on reducing complications of cardiac surgery, reinfection, and post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with previous SARS-CoV-2 infection: a randomized clinical trial (PEP Trial).
N/A
Sci Bull (Beijing)
2025 Jun 30
5.08
1
11
40579769
Impact of the COVID-19 pandemic on TB epidemiology.
N/A
Int J Tuberc Lung Dis
2025 Jun 27
4.1
1
12
40560295
Obstructive sleep apnea is a risk factor for incident COVID-19 infection.
N/A
Sleep Breath
2025 Jun 25
2.42
1
13
40591941
The Heterogeneous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination.
N/A
Retina
2025 Jun 23
6.7
1
14
40542180
Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality.
N/A
Bone Marrow Transplant
2025 Jun 20
4.84
1
15
40537470
Author Correction: No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations.
N/A
Nat Commun
2025 Jun 19
11.8
1
16
40521866
Comparative strategies for overcoming pseudohypoxaemia: Guided by a case of leukocyte larceny in COVID-19 severe acute respiratory distress syndrome with chronic myelogenous leukaemia.
N/A
Anaesth Intensive Care
2025 Jun 16
0.99
1
17
40527619
Corrigendum to "Longitudinal Assessment of lung function in patients following COVID-19" [Respir Med. 243 (2025 Apr 29) 108130. doi: 10.1016/j.rmed.2025.108130. Online ahead of print. PMID: 40311850].
N/A
Respir Med
2025 Jun 16
3.095
1
18
40517053
Comment on "microbial dynamics, risk factors and outcomes of secondary pneumonia in critically ill patients with COVID-19".
N/A
J Formos Med Assoc
2025 Jun 13
2.16
1
19
40498083
Combined FDG-PET/MRI, 4D Flow, and Blood Biomarker Evaluation of Vascular Inflammation and Endothelial Activation After COVID-19.
N/A
Can Assoc Radiol J
2025 Jun 11
1.03
1
20
40187968
A modified cut-off index for the Elecsys Anti-SARS-CoV-2 nucleocapsid electrochemiluminescence immunoassay.
N/A
Pathology
2025 Jun
3.744
1
21
40444914
Airway Immune Signatures in Severe and Fatal Infection with COVID-19.
N/A
Am J Respir Cell Mol Biol
2025 Jun
3.94
1
22
40382018
Letter to the editor on "Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens".
N/A
Am J Infect Control
2025 Jun
2.03
1
23
40382019
Letter to the editor on "Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens".
N/A
Am J Infect Control
2025 Jun
2.03
1
24
40343746
From small Dutch cohort studies to large-scale nationwide data: impact of COVID-19 on the risk of pulmonary embolism.
N/A
Eur Heart J
2025 May 9
12.33
1
25
40349209
Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease.
N/A
Inflamm Bowel Dis
2025 May 9
8
1